Literature DB >> 11288990

Surgical treatment of hyperthyroidism: a ten-year experience.

P Werga-Kjellman1, J Zedenius, L Tallstedt, F Träisk, G Lundell, G Wallin.   

Abstract

Hyperthyroidism is treated either by antithyroid drugs, radioiodine (I131) or surgery. In Sweden, surgery is often performed in patients with large goiter or severe hyperthyroidism with infiltrative endocrine ophthalmopathy. To evaluate indications and results of surgical treatment, data from 380 patients operated on for hyperthyroidism at our department during 1986-1995 were analyzed. Twenty-six percent were referred for surgery because of failure of treatment with antithyroid drugs or I131. Ninety-one percent were subjected to subtotal thyroidectomy with a median remnant weight of less than 2 g. In the remaining patients, total thyroidectomy was performed. Transient vocal cord affection occurred in 2.6%, none of which was permanent. Prolonged postoperative hypocalcemia occurred in 3.1%, and permanent hypoparathyroidism in 1%. There was no difference in complication rate between subtotal or total thyroidectomy. In patients with Graves' disease, 5% worsened with regard to ophthalmopathy initially after surgery but later improved. Recurrent disease occurred in 2% of the patients, all of whom had undergone subtotal thyroidectomy. Surgery is not first-line therapy in all patients with hyperthyroidism. However, in experienced hands, surgery is a good therapeutic alternative that can be carried out with no mortality, few complications, and, provided that a minimal remnant is left, very few recurrences.

Entities:  

Mesh:

Year:  2001        PMID: 11288990     DOI: 10.1089/105072501300042947

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  18 in total

1.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

2.  Total thyroidectomy in Basedow-Graves' disease treatment: our experience.

Authors:  M Barbuscia; A Querci; A Tonante; D Paparo; F Taranto; A Ilacqua; E Gagliano; A Milone
Journal:  G Chir       Date:  2015 May-Jun

3.  A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease.

Authors:  Shun-Yu Chi; Kun-Chou Hsei; Shyr-Ming Sheen-Chen; Fong-Fu Chou
Journal:  World J Surg       Date:  2005-01-18       Impact factor: 3.352

4.  Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.

Authors:  Neslihan Basçil Tütüncü; Tanju Tütüncü; Ali Ozgen; Tomris Erbas
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

5.  Results of surgery for toxic multinodular goiter.

Authors:  Antonio Ríos; José M Rodríguez; María D Balsalobre; Nuria M Torregrosa; Francisco J Tebar; Pascual Parrilla
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  Total thyroidectomy for Graves' disease: compliance with American Thyroid Association guidelines may not always be necessary.

Authors:  Myrick C Shinall; James T Broome; Ratnam Nookala; Jennifer B Shinall; Colleen Kiernan; Lee Parks; Carmen C Solórzano
Journal:  Surgery       Date:  2013-09-26       Impact factor: 3.982

7.  Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease.

Authors:  Vincent T Wu; Allison W Lorenzen; Anna C Beck; Vincent J Reid; Sonia L Sugg; James R Howe; Janet H Pollard; Geeta Lal; Ronald J Weigel
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

8.  Subtotal and near total versus total thyroidectomy for the management of multinodular goiter.

Authors:  Michael Vaiman; Andrey Nagibin; Philippe Hagag; Alexey Buyankin; Julian Olevson; Nathan Shlamkovich
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

9.  Medical management of thyroid eye disease.

Authors:  Dawn D Yang; Mithra O Gonzalez; Vikram D Durairaj
Journal:  Saudi J Ophthalmol       Date:  2010-10-26

Review 10.  Hyperthyroidism.

Authors:  Simone De Leo; Sun Y Lee; Lewis E Braverman
Journal:  Lancet       Date:  2016-03-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.